NCT02962778View on ClinicalTrials.gov

RAS Peptide Profiles in Patients With Treatment-resistant Arterial Hypertension

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 11, 2017

Conditions
Hypertension
Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT02962778 - RAS Peptide Profiles in Patients With Treatment-resistant Arterial Hypertension | Biotech Hunter | Biotech Hunter